Chaoyang Dai

Chaoyang Dai, PhD, currently serves as the Sr. Director of Business Development at Frontage Laboratories, Inc., a prominent global CRO, since February 2016. Prior experience includes roles as VP of Operations at Acebright, Inc. from 2011 to 2014, and Principal Scientist at both Merck and Schering-Plough Research Institute from 2009 to 2010 and 2005 to 2009, respectively. Chaoyang held the position of Senior Scientist at Neogenesis Pharmaceuticals from 2001 to 2005 and completed a postdoctoral fellowship at MIT in the Department of Chemistry between 1999 and 2000. Chaoyang Dai's educational background includes a PhD in Chemistry from the University of Waterloo, an MSc in Chemistry, and a BSc in Chemistry, both from Wuhan University.